Results 71 to 80 of about 277,876 (250)
PLoS ONE, 2017 Background Graves’ disease is the most common form of autoimmune thyroid disorder, characterized by hyperthyroidism due to circulating autoantibodies. To address the pathological features and establish a therapeutic approach of this disease, an animal ...
Nan Xia +7 more
semanticscholar +1 more source
Clinical Endocrinology, Volume 102, Issue 4, Page 482-489, April 2025.ABSTRACT Objective To estimate the incidence, prevalence, patient characteristics and healthcare utilization patterns of moderate to severe thyroid eye disease (TED) in the United States. Design Retrospective review of medical and prescription claims data from the Inovalon deidentified claims database. Patients Patients with moderate to severe TED were
Marius N. Stan +8 more
wiley +1 more source
“A 7‐year analysis of complaints related to Asian blepharoplasty”
Journal of Cosmetic Dermatology, Volume 24, Issue 3, March 2025.Abstract Background People often have high expectations for blepharoplasty, and patient complaints can serve as a valuable tool to understand their specific requirements and desired outcomes. Objectives The objective of this study was to analyze blepharoplasty complaints and identify patient concerns regarding postoperative effects, surgical ...
Xueshang Su +7 more
wiley +1 more source
Folia Histochemica et Cytobiologica, 2009 The purpose of the study was to evaluate the percentage of CD4+/CD8+ peripheral T cells expressing CD62L+ and CD54+ in patients with Graves' disease and to assess if these estimations could be helpful as markers of active ophthalmopathy.
Alina Bakunowicz-Lazarczyk +4 more
doaj +1 more source
JGH Open, Volume 9, Issue 2, February 2025.Abstract Methimazole is a commonly prescribed drug for hyperthyroidism and is generally well‐tolerated, with complications occurring in less than 10% of treated patients. To our knowledge, there are approximately 30 reported cases of drug‐induced liver injury (DILI) associated with the use of methimazole in the literature.
Salomon Chamay +5 more
wiley +1 more source
Treatment of ophthalmopathy in the course of Graves’ disease
Journal of Education, Health and Sport, 2019 : Introduction: Graves’ disease is an autoimmune disease in which the TSH receptor (TSHR) is an autoantigen. Its stimulation by antibodies inhibiting thyrotropin binding causes increased secretion of free thyroid hormones and consequently symptoms of ...
Magdalena Woźniak +5 more
doaj +3 more sources
Mechanism of MicroRNA-146a/Notch2 Signaling Regulating IL-6 in Graves Ophthalmopathy
Cellular Physiology and Biochemistry, 2017 Background/Aims: We intended to investigate the significance of microRNA-146a, Notch2 and IL-6 on Graves ophthalmopathy (GO) and the relationships among them.
Ning Wang, Feng-E Chen, Z. Long
semanticscholar +1 more source
Journal of Cosmetic Dermatology, Volume 24, Issue 2, February 2025.ABSTRACT Background The ocular adverse reactions caused by the diffusion of BoNT‐A injection are self‐limiting, with symptoms ameliorating over time. Thyroid‐associated ophthalmopathy (TAO) is an autoimmune disease characterized by symptoms such as exophthalmos, diplopia, and eyelid retraction, which may overlap the side effects of BoNT‐A injections ...
Junli Zou +3 more
wiley +1 more source
Brain and Behavior, Volume 15, Issue 1, January 2025.ABSTRACT Background and Purpose Observational studies have indicated a high occurrence of coexistence between myasthenia gravis (MG) and autoimmune thyroid disease (AITD) in clinical settings, but the causal relationship between the two conditions remains ambiguous.
Yao Wang +6 more
wiley +1 more source
Age Influences the Severity of Graves' Ophthalmopathy
Kaohsiung Journal of Medical Sciences, 2008 This study compared the ocular manifestations of Graves' disease in different age groups and between genders. This was a retrospective study with a chart review of 210 patients seen in the Kaohsiung Veterans General Hospital Ophthalmology Department from
Muh-Chiou Lin +3 more
doaj +1 more source